The Executive Board of the Global Advisory Panel (GAP) on Corporate Governance and Risk Management of Blood Services in Red Cross and Red Crescent Societies endorses the use of ISBT 128 product coding as a risk mitigation strategy to reduce the incidence of labeling-related transfusion errors and will, where appropriate, promote the use of ISBT 128 as a means to minimize risk in the blood collection, processing, testing and transfusion setting.
View the statement here.
24 October 2013
European Blood Alliance
Statement of the European Blood Alliance position on the labelling, coding and identification of blood, blood components, tissues, and cells.
01 October 2010
ISBT Position Paper
This paper contains the Statement of the International Society of Blood Transfusion position on the labelling, coding and identification of blood, blood components, tissues, cells, and organs.
ISBT Position Paper - PDF
United Kingdom National Health Service
The United Kingdom National Health Service has published two articles regarding ICCBBA and ISBT 128 labeling in their latest online issue of NHS Blood and Transplant Matters. The articles can be found on page 13 and 14.
08 June 2010